期刊文献+

脂质体包裹CpG ODN和肿瘤抗原治疗肝癌的免疫效应 被引量:1

Immune Effect of Liposomes Coating CpG ODN and Tumor Antigen for Liver Cancer Treatment
原文传递
导出
摘要 目的探索脂质体、CpG寡核苷酸(ODN)以及Hepa 1-6肝癌细胞裂解物联合应用治疗肝癌的免疫效果。方法建立C57BL/6小鼠肝癌模型,以PBS、ODN+Hep(肝癌细胞Hep)、Lip(Lipofectamine脂质体)+HDN+Hep荷瘤鼠背部皮下注射,各组小鼠肝脏HE染色,FCM检测小鼠脾脏CD3-FITC、CD4-FITC、CD8-FITC、NK1.1-FITC的组成,ELISA法测免疫小鼠血清中IFN-γ、IL-4水平。结果脂质体包裹CpG ODN+Hepa 1-6肝癌细胞裂解物中CD3-FITC、CD4-FITC、CD8-FITC、NK1.1-FITC的体外杀伤活性以及荷瘤小鼠血清中IFN-γ、IL-4水平均显著高于CpG ODN+Hep组以及PBS组。结论脂质体包裹CpG ODN+Hep能显著提高机体的免疫功能,尤其是特异性细胞免疫功能。 Objectives This article discussed the immune effect of combination application of liposomal, CpG ohgodeoxynacleotide ( ODN ) and Hepa I - 6 hepatoma cell lysates for liver cancer treatment. Methods Liver cancer model of C57BL/6 mice was set up. Tumor-bearing mice were sub- cutaneously injected PBS, ODN + Hep, Lip + ODN + Hep treatment and observation. Liver of different group mice used HE staining. FCM detect- ed the formation of spleen CD3 - FITC, CIM - FITC, CD8 - FITC, NK1.1 - FITC. The serum of mice immunized with IFN - y, I L - 4 level was measured by ELISA method. Results The destruction to competence in vitro of liposomes coating CpG ODN + Hepa 1 - 6 and CD3 - F1TC,CD4 - FITC , CD8 - FITC, NK1.1 - FITC in lysate of liver cancer cells and level of IFN - y, IL - 4 in mice serum are much higher than in CpG ODN + Hep group and PBS group. Conclusions Liposomal CpG ODN and Hep can significantly improve immune function, especially the specific cellular immune function.
出处 《中国病案》 2012年第3期66-69,共4页 Chinese Medical Record
关键词 HEPA 1-6 ODN 抗肿瘤免疫 细胞因子 Hepa 1-6 ODN Anti-tumor immunity Cell factor
  • 相关文献

参考文献10

  • 1Butterfield L H,Ribas A,Dissette V B,et al.A phase I/II trialtesting immunization of hepatocellular carcinoma patients withdendritic cells pulsed with four alpha-fetoprotein peptides[J].ClinCancer Res,2006,12,12(9):2817-2825.
  • 2Nakamoto Y,Mizukoshi E,Kitahara M,et al.Prolonged recur-rence-free survival following OK432-stimulated dendritic celltransfer into hepatocellular carcinoma during transarterial embo-lization[J].Clin Exp Immunol,2011,163,163(2):165-177.
  • 3Tatsumi T,Takehara T,Yamaguchi S,et al.Intrahepatic de liv-ery of alpha galactosylceramide-pulsed dendritic cell ssuppressesliver tumor[J].Hepatology,2007,45,45(1):22-30.
  • 4Palmer DH,Midgley RS,Mirza Net al.A phaseⅡstudy of adop-tive immunotherapy using dendritic cells pulsed with tumor lysatein patients with hepatocellular carcinoma[J].Hepatology,2009,49,49:124-135.
  • 5Bertelli R,Neri F,Tsivian M,et al.Endolymphatic immunothera-py in inoperable hepatocellular carcinoma.[J]Transplant Proc,2008,40,40(6):1913-1915.
  • 6Yang W,Guo C,Liu QG,et al.Experimental study of specific im-munotherapy induced by H22autologous tumor as whole tu-morcell vaccine[J].Biomed Pharmacother,2009,63,63(6):404-408.
  • 7D Hui,L Qiang,W Jian,Z Ti,K Da-Lu.A randomized,controlledtrial of postoperative adjuvant cytokine-induced killer cells im-munotherapy after radical resection of hepatocellular carcinoma[J].Dig Liver Dis.2009,41,41:36-41.
  • 8CM Lo,CL Liu,SC Chan.A randomized,controlled trial of post-operative adjuvant interferon therapy after resection of hepatocellu-lar carcinoma[J].Ann Surg 2007,245,245:831-842.
  • 9Mazzaferro V,Romito R,Schiavo M,et al.Prevention of hepato-cellular carcinoma recurrence with alpha-interferon after liver re-section in HCV cirrhosis[J].Hepatology,2006,44,44(6):1543-1554.
  • 10Gao Q,Qiu SJ,Fan J,et al.Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocel-lular carcinoma after resection[J].J Clin Oncol,2007,25,25(18):2586-2593.

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部